Tumor cells express programmed cell death ligand-1 (PD-L1), which interacts with programmed death-1 (PD-1) on the T cell, counteracting the T cell receptor (TCR) signaling cascade by Src homology-2 domain-containing phosphatase 2 (SHP2) (2). The gene discussed is CD274; the disease is neoplasm.